Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Acute Myeloid Leukemia Topic Center

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
From Population Health
News
New Guidelines Address for Care of Older Adults With AML
08/12/2020
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of...
08/12/2020
First Report Managed Care
News
Substantial Economic Burden Accompanies Various AML Treatments
07/14/2020
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were...
07/14/2020
First Report Managed Care
News
Palliative Care Proves Beneficial in Treatment of Patients With AML
06/03/2020
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid...
06/03/2020
First Report Managed Care
News
Examining Health Care Utilization, Clinical Burden of AML for Payers
05/07/2020
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of...
05/07/2020
First Report Managed Care
News
Myeloablative Conditioning Improves Survival Among Patients With AML
03/05/2020
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that...
03/05/2020
First Report Managed Care
News
Acute Myocardial Infarction Outcomes Worse in Patients With AML
01/31/2020
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients,...
01/31/2020
First Report Managed Care
News
Lower Costs, Improved Survival Linked With Nonmyeloablative Conditioning for AML
01/15/2020
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning...
01/15/2020
First Report Managed Care
Formulary Frontlines®
Exploring Treatment for Acute Myeloid Leukemia
06/18/2019

Edan Stanley

Edan Stanley
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute...
06/18/2019
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Acute Myeloid Leukemia
10/26/2017

S Russell Spjut, PharmD, clinical pharmacist of formulary management at MagellanRx Management

S Russell Spjut, PharmD, clinical pha...
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
News
Integrated Genetic Profiling in Acute Myeloid Leukemia
07/23/2012

Kevin L. Carter

Kevin L. Carter
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations...
07/23/2012
First Report Managed Care

Newsfeed

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
News
New Guidelines Address for Care of Older Adults With AML
08/12/2020
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of...
08/12/2020
First Report Managed Care
News
Substantial Economic Burden Accompanies Various AML Treatments
07/14/2020
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were...
07/14/2020
First Report Managed Care
News
Palliative Care Proves Beneficial in Treatment of Patients With AML
06/03/2020
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid...
06/03/2020
First Report Managed Care
News
Examining Health Care Utilization, Clinical Burden of AML for Payers
05/07/2020
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of...
05/07/2020
First Report Managed Care
News
Myeloablative Conditioning Improves Survival Among Patients With AML
03/05/2020
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that...
03/05/2020
First Report Managed Care
News
Acute Myocardial Infarction Outcomes Worse in Patients With AML
01/31/2020
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients,...
01/31/2020
First Report Managed Care
News
Lower Costs, Improved Survival Linked With Nonmyeloablative Conditioning for AML
01/15/2020
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning...
01/15/2020
First Report Managed Care
Formulary Frontlines®
Exploring Treatment for Acute Myeloid Leukemia
06/18/2019

Edan Stanley

Edan Stanley
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute...
06/18/2019
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Acute Myeloid Leukemia
10/26/2017

S Russell Spjut, PharmD, clinical pharmacist of formulary management at MagellanRx Management

S Russell Spjut, PharmD, clinical pha...
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
Luke Greenwalt
Insights into the 2024 Payer Landscape: Enhancing Patient Care Opportunities
05/07/2024

Featuring Luke Greenwalt, Vice President, Market Access, IQVIA

Featuring Luke Greenwalt, Vice Presid...
Guest speaker from the Asembia AXS24 summit emphasizes the need for early payer involvement in drug development and highlights the challenges and complexities surrounding drug coverage in an interview with First Report Managed Care. Luke...
Guest speaker from the Asembia AXS24 summit emphasizes the need for early payer involvement in drug development and highlights the challenges and complexities surrounding drug coverage in an interview with First Report Managed Care. Luke...
Guest speaker from the Asembia...
05/07/2024
First Report Managed Care
Jay Ackerman Headshot
Interview
AI's Impact on Value-Based Care Outcomes
05/07/2024
Jay Ackerman, President & CEO, Reveleer
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence...
05/07/2024
First Report Managed Care
Anne Headshot
Commentary
Long-Term, High-Impact Nursing Care Solutions Promote High-Value Care
05/06/2024
Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is...
05/06/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
Conference Coverage
What Does Value Mean to You: Value-Based Contracting Expert Insights
05/02/2024
Danielle Sposato
A panel at Asembia 2024 delved into the complexities of value-based contracting in health care, emphasizing the need for collaboration among stakeholders to address key issues and improving access to medicines for patients.
A panel at Asembia 2024 delved into the complexities of value-based contracting in health care, emphasizing the need for collaboration among stakeholders to address key issues and improving access to medicines for patients.
A panel at Asembia 2024 delved...
05/02/2024
First Report Managed Care
Conference Coverage
Expanding Pharmacists’ Role in Providing Clinical Care: Addressing Public Health Challenges
05/02/2024
Danielle Sposato
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various...
05/02/2024
First Report Managed Care
Conference Coverage
Addressing Cost & Accessibility for Innovative Medicines: GLP-1s and Beyond
05/02/2024
Danielle Sposato
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation,...
05/02/2024
First Report Managed Care
Conference Coverage
Rare Orphan, Oncology, and Specialty Drugs in Development: Review of Therapeutic Areas, Designations, and Launch Projections
05/01/2024
Danielle Sposato
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline...
05/01/2024
First Report Managed Care
Conference Coverage
Specialty Pharmaceuticals Pipeline: Biologic and Biosimilar Approvals and Projected Developments
04/29/2024
Hannah Musick
Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.
Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.
Explore the latest trends and...
04/29/2024
First Report Managed Care
News
Analysis Shows Proposed CMS ‘Best Price’ Rule May Increase Rebate Liability, Impacting Medicaid
04/26/2024
Dean Celia
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for...
04/26/2024
First Report Managed Care

Advertisement

Insights

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

What's Trending?

Jay Ackerman Headshot
Interview
AI's Impact on Value-Based Care Outcomes
05/07/2024
Jay Ackerman, President & CEO, Reveleer
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence...
05/07/2024
First Report Managed Care
Anne Headshot
Commentary
Long-Term, High-Impact Nursing Care Solutions Promote High-Value Care
05/06/2024
Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is...
05/06/2024
First Report Managed Care
News
Debate Emerges Over FDA's Plan to Regulate Laboratory Medical Tests
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
Shannon Smith Headshot
Commentary
Adapting to Change: Navigating the New CMS Prior Authorization Guidelines in Health Care
04/02/2024

Shannon Smith, RN, BSN

Shannon Smith, RN, BSN
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry...
04/02/2024
First Report Managed Care
News
Analysis Shows Proposed CMS ‘Best Price’ Rule May Increase Rebate Liability, Impacting Medicaid
04/26/2024
Dean Celia
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for Medicare & Medicaid Services (CMS), “Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program,” has been in the spotlight recently. Major health...
A proposed rule from Centers for...
04/26/2024
First Report Managed Care

Video Insights

Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
kevin cowart md
Videos
Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others
10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant...
10/24/2023
First Report Managed Care
John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023

Featuring John Hennessey, MBA

Featuring John Hennessey, MBA
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
Videos
AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS
10/20/2023

Featuring Andrew Brunner, MD

Featuring Andrew Brunner, MD
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner...
10/20/2023
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care

Advertisement

Advertisement

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement